Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# robots.txt for kirby 2.0.x# robots.txt for # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html # User-agent: * Disallow: /content/*.txt$ Disallow: /kirby/ Disallow: /site/ Disallow: /panel/ Disallow: /*.md$ |
Title | Home | |
Description | Transforming science into BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical |
Keywords | N/A |
WebSite | biolinerx.com |
Host IP | 89.200.137.201 |
Location | United Kingdom |
Site | Rank |
US$18,911,855
Last updated: 2022-06-25 04:48:55
biolinerx.com has Semrush global rank of 559,665. biolinerx.com has an estimated worth of US$ 18,911,855, based on its estimated Ads revenue. biolinerx.com receives approximately 2,182,138 unique visitors each day. Its web server is located in United Kingdom, with IP address 89.200.137.201. According to SiteAdvisor, biolinerx.com is safe to visit. |
Purchase/Sale Value | US$18,911,855 |
Daily Ads Revenue | US$17,458 |
Monthly Ads Revenue | US$523,713 |
Yearly Ads Revenue | US$6,284,555 |
Daily Unique Visitors | 145,476 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
biolinerx.com. | A | 300 | IP: 89.200.137.201 |
biolinerx.com. | NS | 300 | NS Record: ns.barak.net.il. |
biolinerx.com. | NS | 300 | NS Record: ns1.barak.net.il. |
biolinerx.com. | MX | 300 | MX Record: 0 biolinerx-com.mail.protection.outlook.com. |
biolinerx.com. | TXT | 300 | TXT Record: zH58DJq6A34eJoE2kYtUm7hc42MRCE3lEAJr6mhtz8F/bPnsHnVOs8P1sgNWVx/J5XgDfxyOqTvop7O8enCllQ== |
biolinerx.com. | TXT | 300 | TXT Record: MS=ms98375525 |
biolinerx.com. | TXT | 300 | TXT Record: v=spf1 ip4:62.90.205.130 include:spf.protection.outlook.com -all |
BioLineRx About Our Team Board of Directors Pipeline Motixafortide (BL-8040) AGI-134 Clinical Studies Partnering Investors Share Performance News & Events Financials Analyst Coverage SEC Filings Corporate Governance Information Request IR Contacts Careers Contact About About Our Team Board of Directors Pipeline Pipeline Motixafortide (BL-8040) AGI-134 Clinical Studies Partnering Investors Share Performance News & Events Financials Analyst Coverage SEC Filings Corporate Governance Information Request IR Contacts Careers Contact Transforming science into medicine ‘We are committed to developing novel compounds in oncology that will deliver life-changing innovations for patients.’ Philip Serlin, CEO Press Release March 16, 2022 BioLineRx Reports Year-End 2021 Financial Results and Provides Corporate… Events Corporate Presentation Pipeline Motixafortide (BL-8040) Stem Cell Mobilization Motixafortide (BL-8040) blocks the interaction between CXCL12 and CXCR4 leading to robust mobilization |
HTTP/1.1 301 Moved Permanently Date: Mon, 25 Oct 2021 01:12:40 GMT Server: Apache Location: http://www.biolinerx.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 301 Moved Permanently Date: Mon, 25 Oct 2021 01:12:41 GMT Server: Apache Location: https://www.biolinerx.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Mon, 25 Oct 2021 01:12:42 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate Pragma: no-cache Set-Cookie: kirby_session=8b46ed6a68122ea520ccce5f480b2b73; path=/; secure; HttpOnly Content-Type: text/html; charset=UTF-8 |
Domain Name: BIOLINERX.COM Registry Domain ID: 98325382_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domainthenet.com Registrar URL: http://www.DomainTheNet.com Updated Date: 2021-04-04T11:39:06Z Creation Date: 2003-05-25T09:07:31Z Registry Expiry Date: 2023-05-25T09:07:31Z Registrar: Domain The Net Technologies Ltd. Registrar IANA ID: 10007 Registrar Abuse Contact Email: abuse@dtnt.com Registrar Abuse Contact Phone: 972-3-7600500 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: CUSTDNS.BARAKITC.CO.IL Name Server: NS.BARAK.NET.IL DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T06:15:57Z <<< |